OptimizeRx (OPRX) Long-Term Investments (2022 - 2024)

OptimizeRx's Long-Term Investments history runs 3 years deep, the most recent figure standing at $434000.0 for Q2 2024.

• In Q2 2024, Long-Term Investments changed N/A year-over-year to $434000.0; the TTM figure through Jun 2024 stood at $434000.0 (changed N/A YoY), while the FY2023 annual figure was $568000.0, down 98.98% from the prior year.
• Long-Term Investments came in at $434000.0 for Q2 2024 at OptimizeRx, down from $501000.0 in the prior quarter.
• In the past five years, Long-Term Investments ranged from a high of $55.9 million in Q4 2022 to a low of $434000.0 in Q2 2024.
• A 3-year average of $11.6 million and a median of $568000.0 in 2023 frame the typical range for Long-Term Investments.
• On a YoY basis, Long-Term Investments climbed as much as 98.98% in 2023 and fell as far as 98.98% in 2023.
• OptimizeRx's Long-Term Investments stood at $55.9 million in 2022, then tumbled by 98.98% to $568000.0 in 2023, then declined by 23.59% to $434000.0 in 2024.
• According to Business Quant data, Long-Term Investments over the past three periods registered $434000.0, $501000.0, and $568000.0 for Q2 2024, Q1 2024, and Q4 2023 respectively.

Peer Comparison